分流的临床试验
总计1726个结果
-
Memorial Sloan Kettering Cancer Center招聘中
-
Shanghai Junshi Bioscience Co., Ltd.主动,不招人
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis Pharmaceuticals招聘中乳腺癌 | 三阴性乳腺癌 | 乳腺癌女性 | HER2 阴性乳腺癌 | 激素受体阴性乳腺癌三联美国
-
Peregrine Pharmaceuticals撤销乳腺癌 | 三阴性乳腺癌 | 三阴性乳腺肿瘤 | 三阴性乳腺癌 | 三阴性乳腺肿瘤 | ER 阴性 PR 阴性 HER2 阴性乳腺肿瘤 | ER 阴性 PR 阴性 HER2 阴性乳腺癌
-
Yuan YuanGateway for Cancer Research; Agenus Inc.招聘中
-
OHSU Knight Cancer InstituteAstraZeneca; Oregon Health and Science University招聘中解剖学 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌美国
-
Merrimack PharmaceuticalsSanofi完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)撤销II期乳腺癌 | IIIA期乳腺癌 | 三阴性乳腺癌
-
European Organisation for Research and Treatment...AstraZeneca撤销BRCA1突变 | BRCA2突变 | TNBC - 三阴性乳腺癌
-
Vanderbilt University Medical CenterNational Cancer Institute (NCI); Meharry-Vanderbilt Alliance完全的
-
Universidade Estadual de Ponta GrossaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.完全的
-
Melinda TelliPfizer; BioMarin Pharmaceutical完全的
-
Emory UniversityNational Cancer Institute (NCI)招聘中
-
Quiropraxia y EquilibrioUniversidad Nacional Andres Bello完全的
-
Roswell Park Cancer Institute尚未招聘解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌 | 局部晚期不可切除的三阴性乳腺癌美国
-
National Cancer Institute (NCI)暂停解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌 | 不可切除的三阴性乳腺癌美国
-
Orton Orthopaedic HospitalTampere University; Biomendex Oy; Oral Hammaslääkärit Oy, Qmedical Pikku Huopalahti终止
-
University of OklahomaACE Surgical Supply, Inc.完全的
-
Children's Oncology GroupNational Cancer Institute (NCI); Pediatric Brain Tumor Consortium主动,不招人
-
University of WashingtonAbbVie不再可用